Apart from its relevance as favorable prognostic indicator for breast cancer, Sema3B is also under consideration for innovative therapeutic approaches, although caveats remain based on a previous report suggesting that its tumor suppressing activity may trigger rebound inflammatory and prometastatic effects 11. This evidence concerns the gene SEMA3B and neoplasm.